Open position at LABION (Fondazione Don Gnocchi, Milan) for a junior researcher with a Master degree in Chemistry or Pharmaceutical Chemistry and Technology, with a maximum of 2 years of job experience.
If you are interested kindly...
On Friday 21st April, LABION attended the final dissemination event of the FET-PROACT project MARVEL .
As assessed by the Orginizers, Dr. Marina Cretich and Dr. Alessandro Gori of CNR SCITEC,
"The workshop initiative aims to bring together experts and young investigators from different countries working in the...
Extracellular Vesicles are complex and marvellous, with remarkable potential for drug delivery and biomarker discovery!
Still, so many issues have to be solved before being able to translate EV research results to clinics.
The LABION team is working...
NEVERMIND newsletter of December is now online!
News from literature about research advances for the treatment of Alzheimer’s disease and Glioblastoma.
The Nevermind consortium wishes you all Merry Christmas and a happy 2023!
For us, science is not just a job, is an attitude... and it is SUPER FUN!
And we really enjoy it! You can tell by looking...
News from literature about research advances Alzheimer's disease and in drug delivery to the brain.
We are also ready to take part at new conferences in December!
Enjoy your reading!
News from literature and from special awards in the October Newsletter of the #Nevermind project!
You can also have a look at a short and simple video explaining the idea of the NEVERMIND project!
Enjoy your reading!
... 
During the day, the Scientific Director of Fondazione Don Gnocchi , Prof. Eugenio Guglielmelli, presented the results and perspectives of the work of the researchers: "In the last year, over 30 new projects have been launched,... 
The main purpose of NanoInnovation 2022 is to present to...
Labion is a newly established but already International recognized, research laboratory focused on the
application of advanced optical techniques and nanomaterials in medicine.
Several scientific articles, international patents and granted project s are the result of innovation and networking actions.
We develop new nanotechnologies and new biophotonics methods by using a multidisciplinary approach at the level of molecules, cells and tissues.